Evidence map›Paper›PMID 33257567›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

TAT-RasGAP

Marc Serulla, Gabriel Ichim, Filip Stojceski, Gianvito Grasso, Sergii Afonin, Mathieu Heulot, Tim Schober, Robyn Roth, Cédric Godefroy, Pierre-Emmanuel Milhiet and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Marc SerullaDepartment of Biomedical Sciences, University of Lausanne, 1005 Lausanne, Switzerland.ORCID 0000-0002-4166-1556
Gabriel IchimCenter for Research on Cancer of Lyon, LabEX DEVweCAN, University of Lyon, 69008 Lyon, France.ORCID 0000-0002-8386-7405
Filip StojceskiDalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, 6962 Lugano-Viganello, Switzerland.ORCID 0000-0001-8778-8395
Gianvito GrassoDalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, 6962 Lugano-Viganello, Switzerland.ORCID 0000-0002-7761-222X
Sergii AfoninInstitute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology, 76021 Karlsruhe, Germany.ORCID 0000-0002-2356-4226
Mathieu HeulotDepartment of Biomedical Sciences, University of Lausanne, 1005 Lausanne, Switzerland.ORCID 0000-0001-9641-941X
Tim SchoberInstitute of Organic Chemistry, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.ORCID 0000-0003-3003-6816
Robyn RothWashington University Center for Cellular Imaging, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0001-7823-776X
Cédric GodefroyCentre de Biochimie Structurale, CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Pierre-Emmanuel MilhietCentre de Biochimie Structurale, CNRS, INSERM, University Montpellier, 34090 Montpellier, France.ORCID 0000-0002-0410-5956
Kushal DasInterfaculty Institute of Biochemistry, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.ORCID 0000-0003-1149-1813
Ana J García-SáezInterfaculty Institute of Biochemistry, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-3894-5945
Andrea DananiDalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, 6962 Lugano-Viganello, Switzerland.ORCID 0000-0001-6578-5089
Christian WidmannDepartment of Biomedical Sciences, University of Lausanne, 1005 Lausanne, Switzerland; christian.widmann@unil.ch.ORCID 0000-0002-6881-0363
University of Applied Sciences and Arts of Southern Switzerland · CHUniversity of Lausanne · CHCentre National de la Recherche Scientifique · FRKarlsruhe Institute of Technology · DEUniversity of Tübingen · DEUniversité Claude Bernard Lyon 1 · FRWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TAT-RasGAP

Indexed as

AnimalsCell DeathCell MembraneCHO CellsCricetulusGTPase-Activating ProteinsHeLa CellsHumansLiposomesMicroscopy, ElectronMolecular Dynamics SimulationNeoplasmsNuclear Magnetic Resonance, BiomolecularPeptide FragmentsPhosphatidylinositol 4,5-DiphosphatePhosphatidylserinesGTPase-Activating ProteinsLiposomesPeptide FragmentsPhosphatidylinositol 4,5-DiphosphatePhosphatidylserinesTAT-RasGAP(317-326)anticancer peptidescell-penetrating peptidesmembranolytic peptidesphosphatidylserinephosphoinositides

Identifiers

PMID33257567
PMCPMC7749316
OpenAlexW3110626202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.